Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

Search

Search

Popular Search Terms:
Companies / How to Trade / CEO & Team / Contact / List of Brokers

PPM:JPJ

500.0 GBX

AGRW1:JPJ

2.00 GBX

AGRW2:JPJ

2.0 GBX

AMT:JPJ

80.0 GBX

BIB:JPJ

TBC GBX

BVX:JPJ

10.5 GBX

BLVN:JPJ

0.28 GBX

CDR:JPJ

45.0 GBX

CMB:JPJ

0.45 GBX

CSS:JPJ

12.0 GBX

DEST:JPJ

3.00 GBX

ETX:JPJ

15.0 GBX

ERS:JPJ

5.0 GBX

FCRM:JPJ

0.17 GBX

GEEC:JPJ

4.2 GBX

GSV:JPJ

53.0 GBX

GYG:JPJ

30.15 GBX

HVS:JPJ

5.00 GBX

IBPO:JPJ

59.8 GBX

ITHL:JPJ

475.0 GBX

IPG:JPJ

66.7 GBX

LDSG:JPJ

6.25 GBX

LEXW:JPJ

1.0 GBX

LOOP:JPJ

0.7 GBX

LPM:JPJ

45.0 GBX

MEN:JPJ

7.5 GBX

OMM:JPJ

150.0 GBX

MEAL:JPJ

1.5 GBX

PRAX1:JPJ

1.77 GBX

PRAX2:JPJ

2 GBX

QFH:JPJ

2200.0 GBX

QUIZ:JPJ

0.64 GBX

REC:JPJ

0.035 EUR

REDX:JPJ

15.0 GBX

RGH:JPJ

70.0 GBX

SCHO:JPJ

44.0 GBX

SND:JPJ

1.35 GBX

SPO:JPJ

85.0 GBX

SDRY:JPJ

3.29 GBX

TAL:JPJ

3 GBP

TNDE:JPJ

2.0 GBX

INGT:JPJ

43.0 GBX

THRV:JPJ

188.0 GBX

PPM:JPJ

500.0 GBX

AGRW1:JPJ

2.00 GBX

AGRW2:JPJ

2.0 GBX

AMT:JPJ

80.0 GBX

BIB:JPJ

TBC GBX

BVX:JPJ

10.5 GBX

BLVN:JPJ

0.28 GBX

CDR:JPJ

45.0 GBX

CMB:JPJ

0.45 GBX

CSS:JPJ

12.0 GBX

DEST:JPJ

3.00 GBX

ETX:JPJ

15.0 GBX

ERS:JPJ

5.0 GBX

FCRM:JPJ

0.17 GBX

GEEC:JPJ

4.2 GBX

GSV:JPJ

53.0 GBX

GYG:JPJ

30.15 GBX

HVS:JPJ

5.00 GBX

IBPO:JPJ

59.8 GBX

ITHL:JPJ

475.0 GBX

IPG:JPJ

66.7 GBX

LDSG:JPJ

6.25 GBX

LEXW:JPJ

1.0 GBX

LOOP:JPJ

0.7 GBX

LPM:JPJ

45.0 GBX

MEN:JPJ

7.5 GBX

OMM:JPJ

150.0 GBX

MEAL:JPJ

1.5 GBX

PRAX1:JPJ

1.77 GBX

PRAX2:JPJ

2 GBX

QFH:JPJ

2200.0 GBX

QUIZ:JPJ

0.64 GBX

REC:JPJ

0.035 EUR

REDX:JPJ

15.0 GBX

RGH:JPJ

70.0 GBX

SCHO:JPJ

44.0 GBX

SND:JPJ

1.35 GBX

SPO:JPJ

85.0 GBX

SDRY:JPJ

3.29 GBX

TAL:JPJ

3 GBP

TNDE:JPJ

2.0 GBX

INGT:JPJ

43.0 GBX

THRV:JPJ

188.0 GBX

Author: JP Jenkins

Posting of Circular and Notice of General Meeting

THG PLC 28 November 2024 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. FOR IMMEDIATE RELEASE 28 November 2024 THG PLC (the “Company”) Posting of Circular […]

Shares soon to be trading on JP Jenkins

13th Nov 2024  ERS:JPJ Eresos Holdings PLC (“Eresos” or “the Company”) Shares soon to be trading on JP Jenkins London, UK, 13th Nov 2024  – Eresos Holdings PLC (ERS:JPJ), today announces its shares are soon to be admitted to trade on JP Jenkins share dealing platform. The Company’s registered address is 85 Great Portland Street, London, United Kingdom, […]

Sondrel announces CEO transition to lead next phase of growth

Sondrel announces CEO transition to lead next phase of growth Oliver Jones to succeed John Chubb as CEO, effective November 1, 2024 Reading UK – 1 November 2024. Sondrel, a leading technology company providing ultra-complex custom chips for leading global technology brands, today announced that Oliver Jones will succeed John Chubb as Chief Executive Officer, effective November 1, 2024. This […]

Sondrel Announces New CEO

Sondrel announces Mark Julio as new CFO Reading UK – 1 November 2024. Sondrel, a leading technology company providing ultra-complex custom chips for leading global technology brands, today announced that Mark Julio is its new group Chief Financial Officer, effective November 1, 2024.  Oliver Jones, Sondrel’s CEO, said, “I am delighted that Mark is joining Sondrel. His years of experience as a […]

#9 Newsletter – JP Jenkins

Ninth Edition This month we announced another new client Bowleven plc, with 2 more to go live very shortly. We have a number of new clients announce this month to go live in November. We highly anticipate the budget, to see what will happen and how this will affect the investment landscape in both public […]

0207 469 0937

info@jpjenkins.com

5th Floor
101 Wigmore St
London
W1U 1QU

Linkedin Facebook X-twitter

Copyright © 2023 JP Jenkins. All rights reserved. JP Jenkins is a trading name of Infinitx Limited a company incorporated in England & Wales with registered number 11551708 and whose registered office is at 101 Wigmore Street, 5th Floor, London, England, W1U 1QU (JPJ). JPJ (FRN 950991) is an appointed representative of Prosper Capital LLP (FRN453007) (Prosper) which is authorised and regulated by the Financial Conduct Authority. This website is a financial promotion by JPJ. It is not intended to be a promotion of any individual investment opportunity and is not an offer to the public. JPJ acts for the companies listed on the website and provides services to authorised brokers but does not act for investors, consumers or any other person. The information on this website is obtained from the companies and other third parties and although JPJ considers these sources to be reliable, it makes no representation as to the accuracy of the information. Neither JPJ, Prosper nor any member of their group provides any advice on investing in unlisted shares generally or in the companies listed on the platform specifically, nor any legal, financial or tax advice of any kind. Nothing on this website and no communication from JPJ should be construed as an investment recommendation. If you have any doubt about the suitability of the investment, or you require financial advice, you should seek a personal recommendation from an appropriately qualified financial advisor. Investing in unlisted shares is high risk and should only be done as part of a diversified portfolio. Please read the RISK WARNINGS before making any investment decisions. Offers are only available through authorised persons. Any person resident outside the United Kingdom should ensure that they are not subject to any local regulations before investing. Nothing on this website constitutes an offer to sell, or a solicitation of an offer to buy, any security to any person in any jurisdiction to whom or in which such offer, solicitation or sale is unlawful. If you have any questions regarding these matters relating to information on this website you should consult a professional adviser.